State of Wisconsin Investment Board
GLUE icon

State of Wisconsin Investment Board’s Monte Rosa Therapeutics GLUE Stock Holding History

State of Wisconsin Investment Board’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.22M Buy
74,197
+54,569
+278% +$1.04M ﹤0.01% 1604
2025
Q4 		$308K Sell
19,628
-207
-1% -$2.79K ﹤0.01% 2153
2025
Q3 		$147K Buy
19,835
+9,400
+90% +$49.8K ﹤0.01% 2294
2025
Q2 		$47.1K Sell
10,435
-27,200
-72% -$121K ﹤0.01% 2297
2025
Q1 		$175K Buy
37,635
+5,253
+16% +$32.2K ﹤0.01% 2121
2024
Q4 		$225K Sell
32,382
-3,918
-11% -$29.4K ﹤0.01% 2113
2024
Q3 		$192K Sell
36,300
-9,200
-20% -$46.4K ﹤0.01% 2161
2024
Q2 		$170K Sell
45,500
-7,300
-14% -$37.2K ﹤0.01% 2175
2024
Q1 		$372K Buy
52,800
+25,000
+90% +$148K ﹤0.01% 1890
2023
Q4 		$157K Sell
27,800
-10,316
-27% -$40.5K ﹤0.01% 2235
2023
Q3 		$183K Buy
38,116
+3,599
+10% +$23.2K ﹤0.01% 2264
2023
Q2 		$236K Buy
34,517
+17,570
+104% +$114K ﹤0.01% 2081
2023
Q1 		$132K Sell
16,947
-1,266
-7% -$8.8K ﹤0.01% 2349
2022
Q4 		$139K Buy
18,213
+5,117
+39% +$42.6K ﹤0.01% 2303
2022
Q3 		$107K Sell
13,096
-991
-7% -$9.1K ﹤0.01% 2517
2022
Q2 		$136K Buy
+14,087
New +$142K ﹤0.01% 2585

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State of Wisconsin Investment Board's GLUE Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Monte Rosa Therapeutics (GLUE) stake by 278% in Q1 2026, buying an estimated $1.04M and bringing the position to 74,197 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

State of Wisconsin Investment Board first reported a position in GLUE in Q2 2022 and has held it in 16 quarters since. 190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • State of Wisconsin Investment Board held 74,197 shares of Monte Rosa Therapeutics worth $1.22M as of Q1 2026.
  • State of Wisconsin Investment Board bought 54,569 Monte Rosa Therapeutics shares in Q1 2026, an estimated $1.04M.
  • Monte Rosa Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1604 holding.
  • State of Wisconsin Investment Board first reported a position in Monte Rosa Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.